Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van den Bulk, Jitske
16  Ergebnisse:
Personensuche X
?
1

Neoantigen Targetability in Progressive Advanced Melanoma:

van den Bulk, Jitske ; Verdegaal, Els M.E. ; van der Ploeg, Manon...
Clinical Cancer Research.  29 (2023)  20 - p. 4278-4288 , 2023
Link: https://doi.org/10.1158/..
 
?
2

CD103 and CD39 coexpression identifies neoantigen-specific ..:

van den Bulk, Jitske ; van der Ploeg, Manon ; Ijsselsteijn, Marieke E...
Journal for ImmunoTherapy of Cancer.  11 (2023)  2 - p. e005887 , 2023
Link: https://doi.org/10.1136/..
 
?
3

γδ T cells are effectors of immunotherapy in cancers with H..:

de Vries, Natasja L. ; van de Haar, Joris ; Veninga, Vivien...
Nature.  613 (2023)  7945 - p. 743-750 , 2023
Link: https://doi.org/10.1038/..
 
?
4

Cancer-specific T helper shared and neo-epitopes uncovered ..:

Hos, Brett J. ; Tondini, Elena ; Camps, Marcel G.M....
Cell Reports.  41 (2022)  2 - p. 111485 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Cancer-specific T helper shared and neo-epitopes uncovered ..:

Hos, Brett J. ; Tondini, Elena ; Camps, Marcel G.M....
Cell Reports.  41 (2022)  8 - p. 111680 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Therapeutic targeting of TGF-β in cancer: hacking a master ..:

van den Bulk, Jitske ; de Miranda, Noel F.C.C. ; ten Dijke, Peter
Clinical Science.  135 (2021)  1 - p. 35-52 , 2021
Link: https://doi.org/10.1042/..
 
?
7

Neoantigen-specific immunity in low mutation burden colorec..:

van den Bulk, Jitske ; Verdegaal, Els M. E. ; Ruano, Dina...
Genome Medicine.  11 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
8

Identification of a neo-epitope dominating endogenous CD8 T..:

Hos, Brett J. ; Camps, Marcel G.M. ; Bulk, Jitske van den...
OncoImmunology.  9 (2019)  1 - p. , 2019
Link: https://doi.org/10.1080/..
 
?
9

Combined evaluation of the FAS cell surface death receptor ..:

Blok, Erik J. ; van den Bulk, Jitske ; Dekker-Ensink, N. Geeske...
Oncotarget.  8 (2017)  9 - p. 15610-15620 , 2017
Link: https://doi.org/10.18632..
 
?
10

CD103 and CD39 coexpression identifies neoantigen-specific ..:

van den Bulk, Jitske ; van der Ploeg, Manon ; Ijsselsteijn, Marieke E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933759/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

γδ T cells are effectors of immunotherapy in cancers with H..:

de Vries, Natasja L ; van de Haar, Joris ; Veninga, Vivien...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876799/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Therapeutic targeting of TGF-β in cancer: hacking a master ..:

van den Bulk, Jitske ; de Miranda, Noel F.C.C ; ten Dijke, Peter
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796313/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

CD103 and CD39 coexpression identifies neoantigen-specific ..:

Sjoerd H van der Burg ; Rebekka Duhen ; Thomas Duhen...
https://jitc.bmj.com/content/11/2/e005887.full.  , 2023
Link: https://doi.org/10.1136/..
 
?
14

Identification of a neo-epitope dominating endogenous CD8 T..:

Brett J. Hos ; Marcel G.M. Camps ; Jitske van den Bulk...
http://dx.doi.org/10.1080/2162402X.2019.1673125.  , 2020
Link: https://doi.org/10.1080/..
 
?
15

Neoantigen-specific immunity in low mutation burden colorec..:

Jitske van den Bulk ; Els M. E. Verdegaal ; Dina Ruano...
https://doi.org/10.1186/s13073-019-0697-8.  , 2019
Link: https://doi.org/10.1186/..
 
1-15